Biochemia Medica, Vol. 21 No. 3, 2011.
Ostalo
Biomarkers of inflammation and cardiac remodeling: the quest of relevant companions for the risk stratification of heart failure patients is still ongoing
Damien Gruson
; Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium
Sylvie A. Ahn
; Division of Cardiology, Cliniques Universitaires St-Luc, Brussels, Belgium
Michel F. Rousseau
; Division of Cardiology, Cliniques Universitaires St-Luc, Brussels, Belgium
Sažetak
Heart failure (HF) is a frequent chronic disease in elderly people and represents a major health and economic burden. The accurate diagnosis of HF and the identification of high risk patients is manda-tory to select the appropriate therapy and care. HF is associated to cardiac remodeling and inflamma-tion and to the release of neurohormones. If natriuretic peptides remain the biomarkers of choice for the diagnosis and the prognosis of HF, several biomarkers related to cardiac remodeling and inflammation are available for testing and may add valuable information for the risk estimation of HF pa-tients and for the selection of the most appropriated therapy. Furthermore, the quest for new efficient biomarkers of cardiac remodeling and inflammation is still ongoing and new candidates have been identified for a potential use in daily clinical practices. However, before their potential translation to routine parameters several challenges ranging form the analytical validation to the cost-effectiveness estimation should be considered.
Ključne riječi
inflammation; remodeling; heart failure; prognosis; biomarkers
Hrčak ID:
72946
URI
Datum izdavanja:
15.10.2011.
Posjeta: 1.770 *